OpenAI invests $30M in Valthos, launches GPT-Rosalind for drug discovery, and partners with Los Alamos to bolster US biodefense and pandemic preparedness.

AI has massive implications for biosecurity, including the creation of biological weapons.

OpenAI invests $30M in Valthos, launches GPT-Rosalind for drug discovery, and partners with Los Alamos to bolster US biodefense and pandemic preparedness.